Cinclus Pharma Holding AB (SE0020388577) — research page
SE · se-cm-kg/XSTO/SE0020388577 · as of 2026-11-06
Identity and listing
The issuer is Cinclus Pharma Holding AB, listed on Nasdaq Stockholm under ticker SE0020388577. Its ISIN is SE0020388577 and its LEI is 549300TJBPSNZ3DO6B42. Security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Cinclus Pharma Holding AB | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0020388577 | source · 2026-11-06 |
| ISIN | SE0020388577 | source · 2026-11-06 |
| LEI | 549300TJBPSNZ3DO6B42 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 35 filings across 30 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 8 days, against a median of 9.5 days for Nasdaq Stockholm issuers. The record holds 7 days from the latest filing to the record date, against a Nasdaq Stockholm median of 7.0 days. The latest filing is dated 2026-10-30 and is of type Total number of voting rights and capital. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 35 | 8 | 7 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-30 | Total number of voting rights and capital | Total number of voting rights and capital | Number of shares and votes in Cinclus Pharma |
| 2026-10-29 | Investor News | Investor News | Invitation to presentation of Cinclus Pharma's third quarter report 2026 |
| 2026-10-27 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | CINCLUS PHARMA'S NOMINATION COMMITTEE FOR THE 2027 ANNUAL GENERAL MEETING APPOINTED |
| 2026-10-20 | Investor News | Investor News | Cinclus Pharma to participate in upcoming investor conferences |
| 2026-10-07 | Other information disclosed according to the rules of the Exchange | Other information disclosed according to the rules of the Exchange | Issuance and repurchase of class C shares for incentive program |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record and its location are not on the record. Auditor changes are not on the record.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as the index carries no lifecycle type for this register. The issuer is listed, not halted.
Orderability
The outcome is not determinable for this issuer. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 4 research houses: ABG Sundal Collier, Stifel, Carnegie Investment Bank AB and Redeye.
| research house | analyst | source · read date |
|---|---|---|
| ABG Sundal Collier | Georg Tigalonov-Bjerke | issuer page · 2026-11-12 |
| Stifel | Oscar Haffen-Lamm | issuer page · 2026-11-12 |
| Carnegie Investment Bank AB | Arvid Necander | issuer page · 2026-11-12 |
| Redeye | issuer page · 2026-11-12 |
Open research
No openly published research notes are on the record for this issuer.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0020388577 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://cincluspharma.com/investors/the-share/analyst-coverage/ (coverage)
- 10.7
- https://mcp.se-cm-kg.ai/record/XSTO/SE0020388577 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0020388577"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:cd9d69d902fdfc78.